K. Korpela

Inhibition of soluble catechol-O-methyltransferase and single-dose pharmacokinetics after oral and intravenous administration of entacapone

T. Ker�nen, A. Gordin, MariAnne Karlsson et al. · European Journal of Clinical Pharmacology · 1994 · 126 citations

Soluble Catechol-o-methyltransferase, Intravenous Administration, Pharmacological Study +6

The Effect of Catechol-O-Methyl Transferase Inhibition by Entacapone on the Pharmacokinetics and Metabolism of Levodopa in Healthy Volunteers

Tapani Keränen, A. Gordin, V‐P. Harjola et al. · Clinical Neuropharmacology · 1993 · 109 citations

Effect of Entacapone, a COMP Inhibitor, on the Pharmacokinetics and Metabolism of Levodopa After Administration of Controlled-Release Levodopa-Carbidopa in Volunteers

S. Ahtila, Seppo Kaakkola, A. Gordin et al. · Clinical Neuropharmacology · 1995 · 55 citations

Medicinal Chemistry, Pharmacological Study, Levodopa-carbidopa Preparation +10

Pharmacokinetics of oral entacapone after frequent multiple dosing and effects on levodopa disposition

Juha Rouru, A. Gordin, Risto Huupponen et al. · European Journal of Clinical Pharmacology · 1999 · 24 citations

Levodopa Disposition, Frequent Multiple Dosing, Pharmacological Study +6

Exclusion of eight genes as mutated loci in congenital nephrotic syndrome of the Finnish type

Marjo Kestilä, Minna Männikkö, Christer Holmberg et al. · Kidney International · 1994 · 22 citations · Full text

Allelic Variant, Mutated Loci, Genetic Disorder +8